An update from the CEO, Rich Uhlig.
I hope everyone is staying safe in these tumultuous times. I wanted to update you on my recent visit to Washington D.C. to engage with key members of Congress and the Executive Branch about our autism saliva test, Clarifi ASD.
My colleagues from Quadrant and I had the great privilege of speaking with Congressman Chris Smith (R-NJ) and Congressman Mike Doyle (D-PA), the Co-Leaders of the Congressional Autism Caucus, as well as Congresswoman Rosa DeLauro (D-CT), Chairwoman of the House Appropriations Subcommittee on Labor, Health and Human Services, and Education, and Senator Chuck Grassley (R-IA), Chairman of the Senate Finance Committee.
We created awareness about the potential to significantly improve the lives of thousands of Americans by widespread adoption of scalable, highly accurate diagnostic tests for autism. Beyond clinical value, improvements to the diagnostic process can lead to a decrease in the lifetime costs of autism. A cost analysis, independently verified by Avalere Health, estimates the cost savings in education to exceed $13 billion/year and the savings in medical and residential care is expected to exceed $11 billion/year (totaling more than $24 billion/year in taxpayer savings).
Needless to say, these figures resonated significantly with the Congresspeople.
What’s more, we have been asked to brief the Congressional Autism Caucus, a bipartisan effort that includes over 180 Members of Congress from over 40 states! We are very honored and excited to be afforded this great opportunity to discuss the needs of children with autism and their families with Members of Congress.
Finally, our clinical and basic science research efforts continue to advance in our three areas of focus: Autism Spectrum Disorder, Parkinson’s Disease and Concussion Injuries. Stay tuned for updates on all of these topics in the coming weeks.
And thank you again for your steadfast support!
With kind regards,
Founder and CEO